About Leap Therapeutics, Inc. - Common Stock (LPTX)
Leap Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies to improve the lives of patients with cancer and other diseases. The company's research primarily centers on advancing novel antibody-based treatments and biologics that target specific pathways involved in tumor growth and immune response. By leveraging cutting-edge scientific advancements, Leap Therapeutics aims to bring new hope to patients through its clinical programs, which explore potential solutions for previously unmet medical needs. The company collaborates with academic institutions and industry partners to accelerate the development of its therapeutic candidates. Read More
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
The Viral Threat Hiding in Plain Sight: Between August 2024 and July 2025, the CDC’s NoroSTAT system recorded 2,675 norovirus outbreaks across the United States. A genetic shift has emerged: the GII.17 strain has overtaken the long-dominant GII.4 lineage , now responsible for roughly 75 percent of reported cases . Health officials warn this strain replacement increases outbreak frequency and severity, as current cleaning and immunity defenses are quickly becoming outdated. Why It Matters
Nika Pharmaceuticals, Inc. (OTCQB: NIKA ), a next-generation biopharmaceutical company focused on immune-strengthening therapeutics, is emerging as a compelling investment opportunity in the global fight against HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, and Diabetes . With a robust pipeline of proprietary drugs and supplements designed to enhance cellular immunity, NIKA is positioned to address multi-billion-dollar markets in both pharmaceuticals and nutraceuticals .
New York, NY – November 12, 2025 – In a move that sent ripples across both the traditional financial markets and the burgeoning cryptocurrency ecosystem, Leap Therapeutics (NASDAQ: LPTX), a biopharmaceutical company previously focused on developing cancer therapies, officially announced its rebranding to Cypherpunk Technologies Inc. The strategic pivot, effective today, sees the newly christened [...]
Roadzen Inc. (NASDAQ: RDZN), a global AI leader in insurance and mobility, announced the completion of a $7 million India financing led by Team India, Quant AMC, Valentis Advisors, and Prime Securities Group , valuing its India unit at $91 million and implying a $2 per share parent valuation — nearly double its current market price .
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
October 6, 2025 – In a seismic shift that reverberated across both traditional financial markets and the burgeoning crypto ecosystem, Leap Therapeutics (NASDAQ: LPTX), a clinical-stage biotechnology company, today announced a landmark private placement deal. The $58.88 million to $58.9 million investment, spearheaded by prominent crypto investors Winklevoss Capital, is set to not only bolster [...]
Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant decline marks a notable correction for the biotechnology company, which had seen its stock surge dramatically in the preceding days,
